NYSE · Drug Manufacturers - General

AbbVie Inc. (ABBV) Stock

$275.98 +1.30% NYSE: ABBV Healthcare

Valuation

MetricValue
Price$275.98
Market Cap$487.59B
P/E Ratio76.45
P/B Ratio-80.97
P/S Ratio7.45
EPS (TTM)$2.37
52-Week High$275.98
52-Week Low$190.75
Dividend Yield2.55%

Financials & Margins

MetricValue
ROE-136.50%
ROA4.67%
ROCE20.19%
Gross Margin32.85%
Operating Margin32.85%
Net Margin9.81%
Debt/Equity-11.93
Current Ratio0.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$56.2B$58.1B$54.3B$56.3B$61.2B
Operating Profit$17.9B$18.1B$12.8B$9.1B$20.1B
Net Profit$11.5B$11.8B$4.9B$4.3B$4.2B
EPS$6.45$6.63$2.72$2.39$2.37
Op Margin31.9%31.2%23.5%16.2%32.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$146.5B$138.8B$134.7B$135.2B$134.0B
Total Liabilities$131.1B$121.5B$124.3B$131.8B$137.2B
Cash$9.7B$9.2B$12.8B$5.5B$5.2B
Borrowings$77.6B$64.2B$60.1B$67.8B$69.1B

Latest News

Johnson & Johnson CFO Says This Drug Is Outperforming ‘Almost Any Launch’ in Recent Memory Barrons.com · Jul 15, 2026 Should You Buy, Sell or Hold ABBV Stock After Its 9% YTD Rise? Zacks · Jul 15, 2026 Citigroup Adjusts Price Target on AbbVie to $260 From $230, Maintains Neutral Rating MT Newswires · Jul 15, 2026 AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It Zacks · Jul 15, 2026 AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap 24/7 Wall St. · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$22.8B$24.9B$22.8B$18.8B$19.0B
Investing Cash Flow$-3.1B$-1.3B$-2.8B$-21.8B$-7.9B
Financing Cash Flow$-1.4B$-2.3B$-2.5B$-1.5B$-912.0M
Net Cash Flow$1.3B$-545.0M$3.6B$-7.3B$-295.0M
Free Cash Flow$22.0B$24.2B$22.1B$17.8B$17.8B

Valuation & Return Ratios

MetricValue
PEG Ratio1.12
EV / EBITDA25.60
FCF Yield4.11%
Quick Ratio0.69
Interest Coverage6.47
Return 1Y19.45%
Return 3Y99.54%
Return 5Y189.00%

Ownership

Insiders Held0.11%
Institutions Held76.85%
Institutions Float Held76.93%
Institutional HolderSharesReport Date
Blackrock Inc.150,698,1252026-03-31
Vanguard Capital Management LLC114,880,3242026-03-31
State Street Corporation81,217,5162026-03-31
JPMORGAN CHASE & CO56,741,6912026-03-31
Vanguard Portfolio Management LLC49,523,0782026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMGNAmgen Inc. $412.50 +1.24% 25.56 $222.63B 2.43%
AZNAstraZeneca PLC $159.80 +0.64% 24.77 $247.83B 1.27%
BMYBristol-Myers Squibb Company $59.67 +0.15% 13.85 $121.89B 4.01%
GSKGSK plc $51.58 — 9.28 $103.73B 3.49%
JNJJohnson & Johnson $259.05 +1.00% 31.35 $624.28B 1.98%

About AbbVie Inc.

AbbVie Inc. is led by CEO Robert A. Michael, employs 55,000 people, headquartered in North Chicago, US, publicly traded since 2013.

AbbVie Inc. (ABBV) stock trades at $275.98 with a market capitalization of $487.59B. The stock is valued at a price-to-earnings (P/E) ratio of 76.45, price-to-book of -80.97, price-to-sales of 7.45. Over the past 52 weeks the stock has ranged between $190.75 and $275.98, and currently trades at its 52-week high. It pays a dividend yielding 2.55%.

On profitability, AbbVie Inc. generates a return on equity (ROE) of -136.50%, return on capital employed of 20.19%, an operating margin of 32.85%, a net profit margin of 9.81%.

In its most recent fiscal year, AbbVie Inc. reported annual revenue of $61.2B, net profit of $4.2B, revenue has compounded at 6.0% a year over the last five years, profit at -1.7% a year.

The balance sheet shows a debt-to-equity ratio of -11.93 — a conservative balance sheet with little leverage risk, a current ratio of 0.67, total assets of $134.0B, $5.2B in cash and equivalents.

ABBV has a beta of 0.28 (less volatile than the overall market).

Related Healthcare Stocks

LLY Eli Lilly and Company $1171.57 +0.17% JNJ Johnson & Johnson $259.05 +1.00% MRK Merck & Company, Inc. Common Stock (new) $144.69 +1.62% UNH UnitedHealth Group Incorporated Common Stock (DE) $375.98 +1.36% NVS Novartis AG $143.67 +0.39% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $654.67 +0.41% AMGN Amgen Inc. $412.50 +1.24% GILD Gilead Sciences, Inc. $149.51 +1.64% ABT Abbott Laboratories $99.93 +1.46% NVO Novo Nordisk A/S $38.18 -0.21% PFE Pfizer, Inc. $28.00 +0.63%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides